FDA Approved: TOPIRAMATE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for topiramate submitted by Upsher-Smith Laboratories, LLC, resulting in an update to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Migraine

Drugs mentioned

• Topiramate (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE)